Mistarz Cecily 4

What Happened

• Cecily Mistarz, a director of Raymond James Financial, received a mix of Deferred Restricted Stock Units (DRSUs) and Restricted Stock Units (RSUs) as board compensation on February 19, 2026. The filing shows grants totaling 1,799 units (1,303 DRSUs + 248 RSUs + 248 RSUs to subsidiary boards).
• The filing also reports conversions/vestings of previously awarded RSUs (entries totalling 1,753 units: 1,253 + 250 + 250). All transactions were reported at $0.00 per share (awards/vests/conversions, not open-market purchases or sales).

Key Details

• Transaction date: February 19, 2026. Filing date: February 23, 2026 (timely).
• Reported amounts: Grants = 1,799 RSU/DRSU units; Vest/Conversions = 1,753 units. All at $0.00 (award/vesting/conversion).
• Shares owned after transaction: Not disclosed in the excerpt provided.
• Footnotes of note:
  • F1/F2: DRSUs convert one-for-one to common shares upon vesting and include cash in lieu of dividends; settlement of DRSUs has been irrevocably elected to be deferred until the second anniversary of the vest date.
  • F3–F5: RSUs represent contingent rights to receive one share plus accrued cash-in-lieu when they vest; certain awards were scheduled to vest at the next annual meeting (or by Mar 15, 2027) and some awards vested in accordance with their terms.
• Transaction codes: A = award/grant; M = exercise/conversion of a derivative (here, conversion/vesting of RSUs/DRSUs).

Context

• These entries reflect routine director compensation and vesting/settlement mechanics (awards converting to shares and deferred settlement), not open-market buying or selling. Because settlement of DRSUs is deferred by election, no immediate receipt of tradable shares or cash sale proceeds is indicated. This type of insider filing documents compensation and ordinary vesting events rather than active investment decisions.